Cargando…
Trials of testosterone replacement reporting cardiovascular adverse events
The numbers of testosterone prescriptions written have increased several-fold worldwide, but the incidence of pathological hypogonadism due to hypothalamic, pituitary, and testicular disease has remained unchanged. Most of these prescriptions are being dispensed to middle-aged and older men who have...
Autores principales: | Gagliano-Jucá, Thiago, Basaria, Shehzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858095/ https://www.ncbi.nlm.nih.gov/pubmed/28782738 http://dx.doi.org/10.4103/aja.aja_28_17 |
Ejemplares similares
-
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015) -
Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015) -
Testosterone Therapy for Men With Age-Related Low Testosterone: Tempest in a Teacup
por: Basaria, Shehzad
Publicado: (2021) -
Testosterone treatment and cardiovascular events in prescription database studies
por: Shores, Molly M
Publicado: (2018) -
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009)